TY  - JOUR
AU  - Sturm, Gunter Johannes
AU  - Herzog, Sereina Annik
AU  - Aberer, Werner
AU  - Alfaya Arias, Teresa
AU  - Antolin-Amerigo, Dario
AU  - Bonadonna, Patrizia
AU  - Boni, Elisa
AU  - Bożek, Andrzej
AU  - Chełmińska, Marta
AU  - Ernst, Barbara
AU  - Frelih, Nina
AU  - Gawlik, Radoslaw
AU  - Gelincik, Asli
AU  - Hawranek, Thomas
AU  - Hoetzenecker, Wolfram
AU  - Jimenez Blanco, Aranzazu
AU  - Kita, Karolina
AU  - Kendirlinan, Reşat
AU  - Košnik, Mitja
AU  - Laipold, Karin
AU  - Lang, Roland
AU  - Marchi, Francesco
AU  - Mauro, Marina
AU  - Nittner-Marszalska, Marita
AU  - Poziomkowska-Gęsicka, Iwona
AU  - Pravettoni, Valerio
AU  - Preziosi, Donatella
AU  - Quercia, Oliviero
AU  - Reider, Norbert
AU  - Rosiek-Biegus, Marta
AU  - Ruiz-Leon, Berta
AU  - Schrautzer, Christoph
AU  - Serrano, Pilar
AU  - Sin, Aytül
AU  - Sin, Betül Ayşe
AU  - Stoevesandt, Johanna
AU  - Trautmann, Axel
AU  - Vachova, Martina
AU  - Arzt-Gradwohl, Lisa
PY  - 2021
DO  - 10.1111/all.14785
UR  - http://hdl.handle.net/10668/17198
T2  - Allergy
AB  - There is controversy whether taking β-blockers or ACE inhibitors (ACEI) is a risk factor for more severe systemic insect sting reactions (SSR) and whether it increases the number or severity of adverse events (AE) during venom immunotherapy (VIT). In...
LA  - en
PB  - Wiley
KW  - ACE inhibitor
KW  - Adverse event
KW  - Beta-blocker
KW  - Systemic insect sting reaction
KW  - Venom immunotherapy
KW  - Anaphylaxis
KW  - Angiotensin-converting enzyme inhibitors
KW  - Bee venoms
KW  - Desensitization, immunologic
KW  - Humans
KW  - Insect bites and stings
KW  - Prospective studies
KW  - Risk factors
TI  - β-blockers and ACE inhibitors are not a risk factor for severe systemic sting reactions and adverse events during venom immunotherapy.
TY  - research article
VL  - 76
ER  -